• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素耐药感染的管理:来自越南的观点。

Management of Antibiotic-Resistant Infection: Perspectives from Vietnam.

机构信息

Departments of GI Endoscopy, 108 Central Hospital, Hanoi, Vietnam.

Departments of Molecular Biology, 108 Central Hospital, Hanoi, Vietnam.

出版信息

Gut Liver. 2019 Sep 15;13(5):483-497. doi: 10.5009/gnl18137.

DOI:10.5009/gnl18137
PMID:31009957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6743798/
Abstract

Antibiotic resistance is the most important factor leading to the failure of eradication regimens. This review focuses on the prevalence of primary and secondary resistance to clarithromycin, metronidazole, amoxicillin, levofloxacin, tetracycline, and multidrug in Vietnam. We searched the PubMed, EMBASE, Vietnamese National Knowledge Infrastructure, and Vietnamese Biomedical databases from January 2000 to December 2016. The search terms included the following: infection, antibiotic (including clarithromycin, metronidazole, amoxicillin, levofloxacin, tetracycline, and multidrug) resistance in Vietnam. The data were summarized in an extraction table and analyzed manually. Finally, Excel 2007 software was used to create charts. Ten studies (three studies in English and seven in Vietnamese) were included in this review. A total of 308, 412, 523, 408, 399, and 268 strains were included in this review to evaluate the prevalence of primary resistance to amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline, and multidrug resistance, respectively. Overall, the primary resistance rates of amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline, and multidrug resistance were 15.0%, 34.1%, 69.4%, 27.9%, 17.9% and 48.8%, respectively. Secondary resistance rates of amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline, and multidrug resistance were 9.5%, 74.9%, 61.5%, 45.7%, 23.5% and 62.3%, respectively. In Vietnam, primary and secondary resistance to is increasing over time and affects the effectiveness of eradication.

摘要

抗生素耐药性是导致根除疗法失败的最重要因素。本综述重点关注越南克拉霉素、甲硝唑、阿莫西林、左氧氟沙星、四环素和多药耐药的原发性和继发性耐药的流行情况。我们在 2000 年 1 月至 2016 年 12 月期间在 PubMed、EMBASE、越南国家知识基础设施和越南生物医学数据库中搜索了以下术语:感染、抗生素(包括克拉霉素、甲硝唑、阿莫西林、左氧氟沙星、四环素和多药)耐药性在越南。数据汇总在提取表中,并手动进行分析。最后,使用 Excel 2007 软件创建图表。本综述共纳入 10 项研究(3 项英文研究,7 项越南文研究)。共纳入 308、412、523、408、399 和 268 株用于评估阿莫西林、克拉霉素、甲硝唑、左氧氟沙星、四环素和多药耐药的原发性耐药率。总体而言,阿莫西林、克拉霉素、甲硝唑、左氧氟沙星、四环素和多药耐药的原发性耐药率分别为 15.0%、34.1%、69.4%、27.9%、17.9%和 48.8%。阿莫西林、克拉霉素、甲硝唑、左氧氟沙星、四环素和多药耐药的继发性耐药率分别为 9.5%、74.9%、61.5%、45.7%、23.5%和 62.3%。在越南,原发性和继发性耐药性随着时间的推移而增加,影响了根除的效果。

相似文献

1
Management of Antibiotic-Resistant Infection: Perspectives from Vietnam.抗生素耐药感染的管理:来自越南的观点。
Gut Liver. 2019 Sep 15;13(5):483-497. doi: 10.5009/gnl18137.
2
Novel and Effective Therapeutic Regimens for in an Era of Increasing Antibiotic Resistance.抗生素耐药性不断增加的时代下针对[具体病症,原文缺失]的新型有效治疗方案
Front Cell Infect Microbiol. 2017 May 5;7:168. doi: 10.3389/fcimb.2017.00168. eCollection 2017.
3
Primary Antibiotic Resistance of Helicobacter pylori in China.中国幽门螺杆菌的原发性抗生素耐药性
Dig Dis Sci. 2017 May;62(5):1146-1154. doi: 10.1007/s10620-017-4536-8. Epub 2017 Mar 17.
4
Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.大剂量质子泵抑制剂、阿莫西林和强力霉素三联疗法对根除幽门螺杆菌无效:一项概念验证研究。
Helicobacter. 2014 Apr;19(2):90-7. doi: 10.1111/hel.12106. Epub 2014 Feb 10.
5
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].[韩国幽门螺杆菌菌株的原发性抗生素耐药性及根据胃肠十二指肠疾病的根除率]
Korean J Gastroenterol. 2011 Dec;58(2):74-81. doi: 10.4166/kjg.2011.58.2.74.
6
The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing.既往根除失败对幽门螺杆菌耐药性的影响:北京 8 年回顾性研究。
Helicobacter. 2021 Aug;26(4):e12804. doi: 10.1111/hel.12804. Epub 2021 Apr 16.
7
Antimicrobial Resistance and the Successful Eradication of -Induced Gastroduodenal Ulcers in Vietnamese Children.抗微生物药物耐药性与越南儿童 - 诱导性胃十二指肠溃疡的成功根除。
Med Arch. 2021 Apr;75(2):112-115. doi: 10.5455/medarh.2021.75.112-115.
8
The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer.中国胃癌高发地区幽门螺杆菌对五种抗生素的耐药性及其影响因素。
BMC Microbiol. 2019 Jul 4;19(1):152. doi: 10.1186/s12866-019-1517-4.
9
ANTIBIOTIC RESISTANCE SURVEILLANCE OF HELICOBACTER PYLORI AT THE BIOBÍO REGION (CHILE) IN A DECADE.十年间智利比奥比奥地区幽门螺杆菌的抗生素耐药性监测
Arq Gastroenterol. 2019 Oct-Dec;56(4):361-366. doi: 10.1590/S0004-2803.201900000-72.
10
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.亚太地区幽门螺杆菌的主要抗生素耐药性:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2017 Oct;2(10):707-715. doi: 10.1016/S2468-1253(17)30219-4. Epub 2017 Aug 7.

引用本文的文献

1
Diminishing Efficacy of Second-Line Levofloxacin-Based Quadruple Therapy in Eradication: A Prospective Real-World Study in Vietnam Amid Rising Antibiotic Resistance.二线左氧氟沙星四联疗法根除幽门螺杆菌的疗效降低:越南抗生素耐药性上升背景下的一项前瞻性真实世界研究
Antibiotics (Basel). 2025 Aug 14;14(8):826. doi: 10.3390/antibiotics14080826.
2
: Routes of Infection, Antimicrobial Resistance, and Alternative Therapies as a Means to Develop Infection Control.感染途径、抗菌药物耐药性以及作为制定感染控制手段的替代疗法
Diseases. 2024 Dec 3;12(12):311. doi: 10.3390/diseases12120311.
3
Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates.

本文引用的文献

1
Molecular Epidemiology of Helicobacter pylori Infection in a Minor Ethnic Group of Vietnam: A Multiethnic, Population-Based Study.越南少数民族人群幽门螺杆菌感染的分子流行病学:一项多民族、基于人群的研究。
Int J Mol Sci. 2018 Mar 1;19(3):708. doi: 10.3390/ijms19030708.
2
Advanced non-cardia gastric cancer and infection in Vietnam.越南的晚期非贲门胃癌与感染
Gut Pathog. 2017 Aug 17;9:46. doi: 10.1186/s13099-017-0195-8. eCollection 2017.
3
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.
通过药敏试验和耐药分离株突变特征分析鉴定人胃内幽门螺杆菌异质性。
Sci Rep. 2024 May 27;14(1):12066. doi: 10.1038/s41598-024-62200-1.
4
Efficacy and safety of seven Chinese patent medicines combined with conventional triple/quadruple therapy for -positive peptic ulcers: a systematic review and network meta-analysis.七种中成药联合常规三联/四联疗法治疗幽门螺杆菌阳性消化性溃疡的疗效及安全性:系统评价和网络荟萃分析。
BMJ Open. 2024 Apr 29;14(4):e074188. doi: 10.1136/bmjopen-2023-074188.
5
Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial).幽门螺杆菌治疗失败的管理:一项基于大量人群的研究(幽门螺杆菌治疗失败试验)
PLoS One. 2023 Nov 30;18(11):e0294403. doi: 10.1371/journal.pone.0294403. eCollection 2023.
6
Treatment of infection and gastric ulcer: Need for novel Pharmaceutical formulation.感染与胃溃疡的治疗:新型药物制剂的需求
Heliyon. 2023 Sep 24;9(10):e20406. doi: 10.1016/j.heliyon.2023.e20406. eCollection 2023 Oct.
7
Current Worldwide Trends in Pediatric Antimicrobial Resistance.当前全球儿科抗菌药物耐药性趋势
Children (Basel). 2023 Feb 18;10(2):403. doi: 10.3390/children10020403.
8
Vietnam Association of Gastroenterology (VNAGE) consensus on the management of infection.越南胃肠病学协会(VNAGE)关于感染管理的共识
Front Med (Lausanne). 2023 Jan 12;9:1065045. doi: 10.3389/fmed.2022.1065045. eCollection 2022.
9
Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.中国东南地区儿童幽门螺杆菌的抗生素耐药性令人震惊,这一情况已持续了 6 年以上。
Sci Rep. 2022 Oct 22;12(1):17754. doi: 10.1038/s41598-022-21661-y.
10
Effects of Quadruple Therapy Combined with Probiotics on -Related Peptic Ulcer.四联疗法联合益生菌对相关性消化性溃疡的影响。
Comput Math Methods Med. 2022 Oct 11;2022:1221190. doi: 10.1155/2022/1221190. eCollection 2022.
亚太地区幽门螺杆菌的主要抗生素耐药性:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2017 Oct;2(10):707-715. doi: 10.1016/S2468-1253(17)30219-4. Epub 2017 Aug 7.
4
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 V/佛罗伦萨共识报告。
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
5
Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam.越南幽门螺杆菌临床分离株的抗菌药物敏感性及克拉霉素耐药模式
F1000Res. 2016 Apr 13;5:671. doi: 10.12688/f1000research.8239.1. eCollection 2016.
6
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.《多伦多成人幽门螺杆菌感染治疗共识》。
Gastroenterology. 2016 Jul;151(1):51-69.e14. doi: 10.1053/j.gastro.2016.04.006. Epub 2016 Apr 19.
7
Effect of Helicobacter pylori Infection on the Composition of Gastric Microbiota in the Development of Gastric Cancer.幽门螺杆菌感染对胃癌发生过程中胃微生物群组成的影响。
Gastrointest Tumors. 2015 May;2(1):14-25. doi: 10.1159/000380893. Epub 2015 Apr 22.
8
Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review.幽门螺杆菌抗生素耐药性的流行情况:近期文献综述
World J Methodol. 2015 Sep 26;5(3):164-74. doi: 10.5662/wjm.v5.i3.164.
9
High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam.越南幽门螺杆菌克拉霉素和甲硝唑耐药背景下左氧氟沙星耐药率高。
Int J Antimicrob Agents. 2015 Mar;45(3):244-8. doi: 10.1016/j.ijantimicag.2014.10.019. Epub 2014 Nov 25.
10
Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection.胃窦和胃体之间不同的抗生素敏感性,可能是幽门螺杆菌感染治疗失败的一个原因。
World J Gastroenterol. 2014 Nov 21;20(43):16245-51. doi: 10.3748/wjg.v20.i43.16245.